This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Founded in 1994, Alexandria Real Estate Equities, Inc. is a Pasadena, CA-based urban office real estate investment trust (REIT) with particular focus on collaborative life science, agtech and technology campuses. The company’s assets are located in the AAA innovation cluster locations of North America, with considerable market presence in Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. The company enjoys a solid 10-year historical occupancy rate of 96% at operating properties in North America.
Key Factors to Impact Prologis' (PLD) Earnings This Season
by Zacks Equity Research
Prologis (PLD) has capacity to offer modern distribution facilities in strategic in-fill locations and leverage on solid market fundamentals. Yet, stiff competition and rising supply remain woes.
Boston Properties (BXP) Sells D.C. Office Building for $119M
by Zacks Equity Research
Boston Properties (BXP) sells International Trade Commission's office building to Boyd Watterson for $118.56 million.
Prologis (PLD) Announces Encouraging Build-to-Suit Activity
by Zacks Equity Research
The growing need for improving supply-chain efficiencies stemming from the e-commerce boom has enabled Prologis (PLD) to report robust built-to-suit activity.
Alexandria (ARE) Prices Public Offering of 6M Common Shares
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) share offering through a forward-sale agreement enables the company to raise growth capital and use it when the need for such capital rises.
Alexandria (ARE) Pleases Investors With 5% Dividend Hike
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) fourth-quarter dividend of 90 cents indicates a 5% increase. It highlights the company's superior cash flow generating ability.
Here's Why You Should Hold on to Alexandria Stock for Now
by Zacks Equity Research
Alexandria's (ARE) high occupancy levels amid elevated demand and limited supply is encouraging. However, earning dilution resulting from its continuous divestures is a concern.
Alexandria Achieves Full Pre-leasing at 100 Binney Street
by Zacks Equity Research
Alexandria Real Estate Equities (ARE) fully pre-leases 100 Binney Street office/laboratory space, scheduled to be delivered in fourth-quarter 2017.
Alexandria Real Estate (ARE) Down 2.1% Since Earnings Report: Can It Rebound?
by Zacks Equity Research
Alexandria Real Estate (ARE) reported earnings about a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Alexandria Real Estate Equities (ARE) Reports In-Line Q2 FFO
by Zacks Equity Research
Alexandria Real Estate Equities' (ARE) Q2 results reflect robust growth in same-property net operating income (NOI) and strong leasing metrics.
REIT Stocks Q2 Earnings Due on Jul 31: VRO, ARE, BRX & NRZ
by Zacks Equity Research
Despite a number of headwinds prevailing in the REIT space, many companies are anticipated to display impressive results, mirroring economic recovery.
Alexandria (ARE) to Post Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Solid demand, strong cash flow and decent balance-sheet position will likely drive Alexandria Real Estate Equities' (ARE) performance in Q2. Let's see if these can lead to an earnings beat.
Alexandria Real Estate (ARE) Announces Hike in Q2 Dividend
by Zacks Equity Research
Alexandria Real Estate Equities, Inc. (ARE) announced second-quarter 2017 cash dividend of 86 cents per share, marking a sequential rise of 4%.
Alexandria Real Estate Prices 6.1M Common Shares Offering
by Zacks Equity Research
Alexandria Real Estate Equities, Inc. (ARE) announced the pricing of public offering of 6.1 million common shares at $108.55 per share.
The Zacks Analyst Blog Highlights: GGP, UDR, Alexandria Real Estate Equities and CBRE Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GGP, UDR, Alexandria Real Estate Equities and CBRE Group
Alexandria Real Estate, Merck Ink Long-Term Pharma Lease
by Zacks Equity Research
Alexandria Real Estate Equities, Inc. (ARE) has announced its tie up with Merck & Co., Inc. (MRK) to operate its new West Coast research facility.